+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Addiction Disorders Drugs Market Research Reports

Nicotine Gum - Global Strategic Business Report - Product Thumbnail Image

Nicotine Gum - Global Strategic Business Report

  • Report
  • July 2026
  • 192 Pages
  • Global
From
From
From
From
From
From
Alcohol Use Disorder - Pipeline Insight, 2026 - Product Thumbnail Image

Alcohol Use Disorder - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 80 Pages
  • Global
From
From
From
From
Smoking Cessation Drug Pipeline Analysis Report 2026 - Product Thumbnail Image

Smoking Cessation Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • May 2026
  • 150 Pages
  • Global
From
Substance Use Disorder (SUD) Pipeline Analysis Report 2026 - Product Thumbnail Image

Substance Use Disorder (SUD) Pipeline Analysis Report 2026

  • Report
  • May 2026
  • 200 Pages
  • Global
From
From
Opioid Related Disorder Pipeline Analysis Report 2025 - Product Thumbnail Image

Opioid Related Disorder Pipeline Analysis Report 2025

  • Report
  • March 2026
  • 200 Pages
  • Global
From
From
From
Smoking Cessation and Nicotine De-Addiction Market 2026-2030 - Product Thumbnail Image

Smoking Cessation and Nicotine De-Addiction Market 2026-2030

  • Report
  • January 2026
  • 291 Pages
  • Global
From
From
From
Loading Indicator

The Addiction Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs used to treat addiction disorders. These drugs are used to treat a variety of conditions, including alcohol and drug addiction, nicotine addiction, and gambling addiction. The market is composed of both generic and branded drugs, with the latter being more expensive. The market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, and Sanofi. These companies are constantly researching and developing new drugs to treat addiction disorders, as well as improving existing treatments. Additionally, many of these companies are involved in clinical trials to test the efficacy of their drugs. Show Less Read more